Published: January 08, 2018
Cancer Research Institute and Canadian Cancer Trials Group Announce Strategic Collaboration

CCTG and CRI collaborate to bring important improvements in cancer therapies to the patients that need them

The Cancer Research Institute (CRI) and the Canadian Cancer Trials Group (CCTG) have announced a multi-year collaboration to develop and conduct clinical trials in immunotherapy.

Published: January 02, 2018
CCTG network researchers have been recognized with the Order of Canada

CCTG network researchers have been recognized by Governor General Julie Payette who announced the Order of Canada appointments on Friday, Dec. 29. Please join us in congratulating Dr. Pritchard, Dr. Gleave and Dr. Eisenhauer on this wonderful honour and for their outstanding contributions to cancer clinical trial research in Canada.

Dr. Elizabeth Eisenhauer, Officer of the Order of Canada

Published: December 05, 2016
CCTG Directors -Dr. Elizabeth Eisenhauer, head of the Queen’s Department of Oncology, Dr. Joe Pater, former CCTG Director, Dr. Janet Dancey, CCTG Director,

Dr. Elizabeth Eisenhauer, head of the Queen’s Department of Oncology, Dr. Joe Pater, former CCTG Director, Dr. Janet Dancey, CCTG Director,

Patients facing a cancer diagnosis invariably have many questions, but one tops the list – what is the best treatment? Answering that question is the compelling goal of medical research that is testing new treatments for similarly-diagnosed patients in carefully monitored and controlled ways. Such studies, known as clinical trials, have been instrumental in altering and improving the way cancer is now approached.

Published: November 06, 2017
Judy’s volunteer work over the past twelve years has evolved into supporting the patient voice in clinical trials research

Judy Needham supporting the patient voice in clinical trials research

The Canadian Cancer Research Alliance (CCRA) has honored members of the research community for their leadership and significant contributions to cancer research in Canada. This year, two new awards have been introduced recognizing exceptional leadership in patient involvement in cancer research.

Published: September 25, 2017
Pancreatic cancer patient Susan Stewart with her family, she enrolled in the CCTG PA.7 immunotherapy and chemotherapy trial

Pancreatic cancer patient Susan Stewart shown here on the right with her family is
enrolled in the CCTG PA.7 immunotherapy and chemotherapy trial

An innovative clinical trial underway across Canada is providing new hope to a B.C. family braving pancreatic cancer – the deadliest cancer facing Canadians today.

Published: September 06, 2017
 Dr Wendy  R.  Parulekar,  Senior  Investigator  at   CCTG
Dr. Wendy R. Parulekar, Senior Investigator MA.39

One of the most promising advances in cancer treatment is the use of biological markers or biomarkers to identify the therapies a particular cancer may or may not respond to. A new study undertaken by the Canadian Cancer Trials Group (CCTG) will look at whether additional radiation therapy is beneficial for patients with a specific subtype of breast cancer called luminal A.

Published: August 15, 2017
Dr. Janet Dancey, CCTG Director and JELF award recipient

Dr. Janet Dancey, CCTG Director and JELF award recipient

The Canadian Foundation for Innovation (CFI) John R. Evans Leaders Fund (JELF) has announced a funding award of $197,065 to allow the Canadian Cancer Trials Group (CCTG) to acquire a state-of-the-art digital histology slide scanner.

Published: July 06, 2017

CCTG Participating Sites and Investigators

As you may be aware, the National Clinical Trials Network (NCTN) of the US NCI is planning to launch a new Registration and Credential Repository (RCR) system and a Delegation of Tasks Log (DTL) in the coming months.  These systems are being developed to address requirements for ICH-GCP compliant conduct for NCTN trials, including documentation of qualifications, training, and study specific delegation of tasks.

Published: June 27, 2017
A patient of Dr. Booth’s in the CCTG Challenge Trial

A patient of Dr. Booth’s in the CCTG Challenge Trial follows her exercise prescription.

Clinical trials don’t always set out to prove whether drugs are effective. They can also test surgeries, radiation therapy, or even exercise. Dr. Christopher Booth was a CCTG research fellow in 2006 when results of a 30-year study in the United States noted that the nurses who exercised were less likely to contract colon cancer. Even more interesting was that those who contracted colon cancer and exercised were less likely to relapse. As a colon cancer specialist, Dr.

Published: June 05, 2017
Canadian Cancer Trials Group at the American Society of Clinical Oncology Annual Meeting 2017

It has been another busy year for Canadian Cancer Trials Group at the American Society of Clinical Oncology Annual Meeting. This conference brings together oncology professionals from around the world to discuss state-of-the-art treatments, new therapies with the best minds in the field of cancer research.

CCTG is well represented on this world stage with three recognition awards, fifteen poster presentations, and four oral abstracts. See below for more details.